Gut Microbiome Predicts Clinically Important Improvement in Patients with Rheumatoid Arthritis

Within the past decade, several studies have shown that dysbiosis of the gut microbiome is a key hallmark of rheumatoid arthritis (RA). Yet, the relationship between gut microbiome and clinical improvement in the disease activity of patients with RA remains. In this study, we explored the gut microbiome of patients with RA to identify features that are associated with, as well as predictive of, minimum clinically important improvement (MCII) in disease activity.